Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by celine.gongora
Group name EquipeCG
Item Type Journal Article
Title Pregnane X-receptor promotes stem cell-mediated colon cancer relapse
Creator Planque et al.
Author Chris Planque
Author Fatemeh Rajabi
Author Fanny Grillet
Author Pascal Finetti
Author François Bertucci
Author Meritxell Gironella
Author Juan José Lozano
Author Bertrand Beucher
Author Julie Giraud
Author Véronique Garambois
Author Charles Vincent
Author Daniel Brown
Author Ludovic Caillo
Author Jovana Kantar
Author Michel Prudhomme
Author Jérémie Ripoche
Author Jean François Bourgaux
Author Christophe Ginestier
Author Antoni Castells
Author Frédéric Hollande
Author Julie Pannequin
Author Jean Marc Pascussi
Abstract Colorectal cancer lethality usually results from post-treatment relapse in the majority of stage II-IV patients, due to the enhanced resistance of Cancer Stem Cells (CSCs). Here, we show that the nuclear receptor Pregnane X Receptor (PXR, NR1I2), behaves as a key driver of CSC-mediated tumor recurrence. First, PXR is specifically expressed in CSCs, where it drives the expression of genes involved in self-renewal and chemoresistance. Clinically, high levels of PXR correlate with poor recurrence-free survival in a cohort of >200 stage II/III colorectal cancer patients treated with chemotherapy, for whom finding biomarkers of treatment outcome is an urgent clinical need. shRNA silencing of PXR increased the chemo-sensitivity of human colon CSCs, reduced their self-renewal and tumor-initiating potential, and drastically delayed tumor recurrence in mice following chemotherapy. This study uncovers PXR as a key factor for CSC self-renewal and chemoresistance and targeting PXR thus represents a promising strategy to minimize colorectal cancer relapse by selectively sensitizing CSCs to chemotherapy.
Publication Oncotarget
Volume 7
Issue 35
Pages 56558-56573
Date Aug 30, 2016
Journal Abbr Oncotarget
Language eng
DOI 10.18632/oncotarget.10646
ISSN 1949-2553
Library Catalog PubMed
Extra PMID: 27448961 PMCID: PMC5302934
Tags Aged, Aldehyde Dehydrogenase, Animals, Antineoplastic Agents, arc, Biomarkers, Tumor, cancer stem cell, Cohort Studies, Colonic Neoplasms, colorectal cancer, Disease-Free Survival, Drug Resistance, Neoplasm, Female, Humans, Labex epigenmed, ligue, Male, Mice, Mice, Inbred BALB C, Mice, Nude, MRI, Neoplasm Recurrence, Local, Neoplasm Transplantation, Neoplastic Stem Cells, original, phd, Pregnane X Receptor, Prognosis, PXR, Receptors, Steroid, Spheroids, Cellular, tumor recurrence
Date Added 2019/05/22 - 08:29:49
Date Modified 2019/10/24 - 17:26:28
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés